Metamodix is a pioneering startup in the health care and manufacturing industries, founded in 2009. The company is dedicated to reducing the human and financial costs of Type 2 Diabetes. Metamodix has developed a drug-free, nonsurgical device therapy that holds the promise to eliminate symptoms and reduce weight in over 300 million patients worldwide suffering from Type 2 Diabetes. In a recent milestone, the company secured a $500.00K Venture Round investment on 26 January 2023. This significant investment signals growing confidence in the potential of Metamodix's innovative approach to addressing a pressing global health issue. As the company continues to advance its groundbreaking therapy, it is positioned to make a substantial impact on the lives of millions of individuals and the healthcare landscape as a whole.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Venture Round | $500.00K | - | 26 Jan 2023 | |
| Venture Round | $100.00K | - | 12 Jul 2018 | |
| Venture Round | $1.20M | - | 29 Mar 2017 | |
| Venture Round | $100.00K | - | 23 Dec 2016 | |
| Venture Round | $141.99K | - | 08 May 2016 |
No recent news or press coverage available for Metamodix.
We care about your data, and we'd love to use cookies make your experience better.
